Palisade Bio, Inc. (PALI)
1.24
+0.12
(+10.71%)
USD |
NASDAQ |
Nov 03, 16:00
1.24
0.00 (0.00%)
After-Hours: 16:25
Palisade Bio Price to Book Value : 1.768 for Nov. 3, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 1.597 |
| October 30, 2026 | 1.654 |
| October 29, 2026 | 1.697 |
| October 28, 2026 | 1.697 |
| October 27, 2026 | 1.711 |
| October 26, 2026 | 1.754 |
| October 23, 2026 | 1.896 |
| October 22, 2026 | 1.925 |
| October 21, 2026 | 1.996 |
| October 20, 2026 | 2.039 |
| October 19, 2026 | 1.911 |
| October 16, 2026 | 2.010 |
| October 15, 2026 | 2.196 |
| October 14, 2026 | 2.110 |
| October 13, 2026 | 2.089 |
| October 12, 2026 | 2.267 |
| October 09, 2026 | 2.196 |
| October 08, 2026 | 2.068 |
| October 07, 2026 | 2.110 |
| October 06, 2026 | 2.125 |
| October 05, 2026 | 2.082 |
| October 02, 2026 | 2.053 |
| October 01, 2026 | 2.039 |
| September 30, 2026 | 1.925 |
| September 29, 2026 | 2.068 |
| Date | Value |
|---|---|
| September 28, 2026 | 2.139 |
| September 25, 2026 | 2.068 |
| September 24, 2026 | 2.239 |
| September 23, 2026 | 2.281 |
| September 22, 2026 | 2.410 |
| September 21, 2026 | 2.410 |
| September 18, 2026 | 2.267 |
| September 17, 2026 | 2.424 |
| September 16, 2026 | 2.410 |
| September 15, 2026 | 2.873 |
| September 14, 2026 | 2.923 |
| September 11, 2026 | 2.937 |
| September 10, 2026 | 2.866 |
| September 09, 2026 | 2.923 |
| September 08, 2026 | 3.137 |
| September 04, 2026 | 2.980 |
| September 03, 2026 | 2.916 |
| September 02, 2026 | 2.838 |
| September 01, 2026 | 2.795 |
| August 31, 2026 | 2.780 |
| August 28, 2026 | 2.852 |
| August 27, 2026 | 3.009 |
| August 26, 2026 | 3.037 |
| August 25, 2026 | 2.952 |
| August 24, 2026 | 2.866 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.710 |
| Alnylam Pharmaceuticals, Inc. | 5.938 |
| Anika Therapeutics, Inc. | 1.885 |
| Savara, Inc. | 6.784 |
| Vericel Corp. | 5.681 |
Price to Book Value Related Metrics
| PS Ratio | 364.54 |
| Price | 1.24 |
| Earnings Yield | -43.17% |
| Market Cap | 215.26M |